Sensitized renal transplant recipients: current protocols and future directions.
about
Persistence of recipient human leucocyte antigen (HLA) antibodies and production of donor HLA antibodies following reduced intensity allogeneic haematopoietic stem cell transplantation.Anti-complement component C5 mAb synergizes with CTLA4Ig to inhibit alloreactive T cells and prolong cardiac allograft survival in mice.The major histocompatibility complex in transplantationAllocating Deceased Donor Kidneys to Candidates with High Panel-Reactive Antibodies.A glow of HLA typing in organ transplantation.Challenges in organ transplantation.Banff 2011 Meeting report: new concepts in antibody-mediated rejectionDetection of IgG antibodies to donor specific HLA class I & II antigens in post renal transplant casesNew immunosuppressive agents in pediatric transplantation.Detection of anti-HLA antibodies by solid-phase assay in kidney transplantation: friend or foe?Innovative strategies in living donor kidney transplantation.Living donor kidney paired donation transplantation: experience as a founding member center of the National Kidney Registry.Incompatible kidney transplantation: a brief overview of the past, present and future.Transplant glomerulopathy: the interaction of HLA antibodies and endotheliumKidney transplantation, bioengineering and regeneration: an originally immunology-based discipline destined to transition towards ad hoc organ manufacturing and repair.Renal transplantation in sensitized children and young adults: a nationwide approach.Deceased donor kidney transplantation across donor-specific antibody barriers: predictors of antibody-mediated rejection.Successful kidney transplantation across a positive complement-dependent cytotoxicity crossmatch by using C1q assay-directed, bortezomib-assisted desensitization: A case reportSingle-center kidney paired donation: the Methodist San Antonio experience.Intravenous human immunoglobulin treatment of serum from HLA-sensitized patients in kidney transplantation.Kidney Transplantation: The Challenge of Human Leukocyte Antigen and Its Therapeutic Strategies.Effect of Treatment With Tabalumab, a B Cell-Activating Factor Inhibitor, on Highly Sensitized Patients With End-Stage Renal Disease Awaiting Transplantation.Long-term histopathology of allografts in sensitized kidney recipients.
P2860
Q34241347-8147EDF2-C049-40BB-B63B-304F408C6545Q35083760-CDA72746-4A80-45FB-911C-A67573EF451BQ36072165-A7D60357-C4EF-40D5-B943-68567980C4C6Q36687017-050B27BE-FEE4-47B7-A8DC-9C9B641B6E8EQ36688282-A92D0DB4-0B07-4203-B94F-512BE2C8D954Q36919516-F30608F2-CBB5-493E-8ABE-511F5950A63DQ37058043-3B068A14-90AD-4015-AAAC-55D99F0DFA12Q37391506-ADE0D6EC-F041-498D-8F59-385B19D846CEQ37446883-7A9E8CEA-9205-4C8C-AD53-4E8888E5E64BQ38001495-64782D58-FB3D-40F0-8B8C-C5E32B64F86CQ38006827-B5EDFE20-CD66-4FFF-84D5-267C7AD85262Q38032838-850C1A18-B1A5-4B91-A5EE-A92EBA8B9DDAQ38036246-866680F1-48F8-46F1-92A2-CDEB450B89B3Q38205229-04A9BDC4-1575-42A3-8BD3-3CD5E1CA1B6DQ38658621-95B5A855-25CE-43A1-9D3C-69C74DAC1C81Q39289605-9391201B-629A-4B02-BF6E-E64E59DD592AQ40749159-3BF47723-86AC-4C3E-93E0-F58BA7BE0635Q42283383-AF9F4A5E-99FA-4597-966F-43B554DDAE49Q44846201-7B01CBE8-E8AA-43D1-8164-3823E833534FQ46436844-906128EE-FE6B-491E-A24B-66076BD53671Q52310243-B7CD13CB-7AB3-4A5E-A52B-AB15C58BB477Q52888455-5EC2EF8B-A2B9-44D0-AD54-EA2B8A042B7CQ53158985-97472AE0-FC6E-41D5-84C0-9FBE7867E2DC
P2860
Sensitized renal transplant recipients: current protocols and future directions.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 16 March 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Sensitized renal transplant recipients: current protocols and future directions.
@en
Sensitized renal transplant recipients: current protocols and future directions.
@nl
type
label
Sensitized renal transplant recipients: current protocols and future directions.
@en
Sensitized renal transplant recipients: current protocols and future directions.
@nl
prefLabel
Sensitized renal transplant recipients: current protocols and future directions.
@en
Sensitized renal transplant recipients: current protocols and future directions.
@nl
P2860
P356
P1476
Sensitized renal transplant recipients: current protocols and future directions.
@en
P2093
James Gloor
Mark D Stegall
P2860
P2888
P304
P356
10.1038/NRNEPH.2010.34
P407
P577
2010-03-16T00:00:00Z